These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22282931)

  • 1. Object-name selection in psychiatric patients before and after neuroleptic therapy.
    Calvert JE; Babiker IE; Harris JP; Phillipson OT; Ford MF; Antebi DL
    J Psychopharmacol; 1990 Jan; 4(2):75-82. PubMed ID: 22282931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term prospective comparison of prepulse inhibition between schizophrenic patients and healthy controls.
    Preuss UW; Zimmermann J; Watzke S; Langosch J; Siafarikas N; Wong JW; Hamm A; Weike A
    Pharmacopsychiatry; 2011 May; 44(3):102-8. PubMed ID: 21432751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overinclusion and transactional thinking on the Object Sorting Test of schizophrenic and nonschizophrenic patients.
    Quinlan DM; Schultz KD; Davies RK; Harrow M
    J Pers Assess; 1978 Aug; 42(4):401-8. PubMed ID: 690802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients.
    Gaertner I; Gilot C; Heidrich P; Gaertner HJ
    Pharmacopsychiatry; 2002 Mar; 35(2):37-43. PubMed ID: 11951144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorder.
    Faragian S; Fuchs C; Pashinian A; Weizman R; Weizman A; Poyurovsky M
    Psychiatry Res; 2012 May; 197(1-2):19-22. PubMed ID: 22436351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depressive syndromes within the scope of schizophrenic psychoses].
    Hinterhuber H; Neumann R
    Wien Med Wochenschr; 1985 Sep; 135(18):435-41. PubMed ID: 3933187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of neuroleptics on facial action in schizophrenic patients.
    Schneider F; Ellgring H; Friedrich J; Fus I; Beyer T; Heimann H; Himer W
    Pharmacopsychiatry; 1992 Sep; 25(5):233-9. PubMed ID: 1357682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral ventricular size, psychopathology, and medication response in the psychoses.
    Luchins DJ; Lewine RR; Meltzer HY
    Biol Psychiatry; 1984 Jan; 19(1):29-44. PubMed ID: 6142730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on relapse of schizophrenic patients--10-year-follow-up investigation after initial admission].
    Uchida S
    Seishin Shinkeigaku Zasshi; 1996; 98(5):299-319. PubMed ID: 8741284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Jockers-Scherübl MC; Wolf T; Radzei N; Schlattmann P; Rentzsch J; Gómez-Carrillo de Castro A; Kühl KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1054-63. PubMed ID: 17482741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC; Yon V; Loas G; Noisette C
    Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
    Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
    Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N; Hirayasu Y; Hiramatsu K; Ohta H
    Seishin Shinkeigaku Zasshi; 1999; 101(3):254-76. PubMed ID: 10375977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benzodiazepine monotherapy in acute schizophrenia].
    Jaspert A; Ebert D
    Nervenarzt; 1994 Jan; 65(1):62-5. PubMed ID: 7908419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
    Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
    Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug prescribing pattern of a psychiatric university hospital in Germany.
    Schmidt LG; Niemeyer R; Müller-Oerlinghausen B
    Pharmacopsychiatria; 1983 Mar; 16(2):35-42. PubMed ID: 6867092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication.
    Halacheva K; Dimova S; Tolev T; Dimov D; Nikolova M
    Psychiatry Res; 2009 Aug; 169(1):51-5. PubMed ID: 19596154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.